Johnson & Johnson

10 Vintage Ads Show How Pharmacy Has Changed
10 Vintage Ads Show How Pharmacy Has ChangedPharmacy has changed a lot in the last 70 years, and these old ads prove it.
Activists: drugmakers, distributors liable for opioids abuseSoon after President Donald Trump announced declared the opioid abuse crisis a “public health emergency," shareholder activist groups said they aim to hold drug manufacturers and distributors liable for their part in the crisis.
$417 Million Award from Lawsuit DroppedA judge tossed an award given to a woman claiming baby powder caused ovarian cancer.
The Sightbox scoop from J&J’s Peter MenziusoIf the rate of change in optometry this year has your head spinning, hold on tight with this next one. On September 18, 2017, Johnson & Johnson Vision (JJV) announced the acquisition of Sightbox, an online contact lens subscription box service that sells direct to consumer Acuvue contact lenses, and yes, contact lenses from the three other major contact lens manufacturers.
How vaping affects the ocular surfaceElectronic cigarettes (e-cigarettes) are devices designed to deliver nicotine in a solution rather than smoke without tobacco combustion. Perceived by consumers as a safer alternative to conventional cigarettes, e-cigarettes are aggressively marketed as lifestyle-choice consumables.
Phaco technology evolves over timeFifty years after the idea for phacoemulsification came to Charles Kelman, MD, few would have predicted that surgical platforms would evolve to where they are today.
What you missed at AOA 2017
What you missed at AOA 2017Catch up with what you missed at Optometry's Meeting in Washington, DC.
FDA clears second Remicade biosimilarIn what is expected to produce hefty saving for rheumatoid arthritis patients and the healthcare system, FDA approved the second biosimilar to Remicade (Johnson & Johnson).
7 tips for safer lens wear with cosmeticsA few tips regarding wearing cosmetics and contact lens wear can help our patients wear their lenses with more comfort.
Johnson & Johnson to acquire Abbott Medical Optics
Johnson & Johnson to acquire Abbott Medical OpticsReady for some big news? Johnson & Johnson announced they have entered into a definitive agreement to acquire Abbott Medical Optics (AMO) for $4.325 billion in cash. AMO’s business segments include cataract surgery, laser refractive surgery, and consumer eye health, and reported sales in 2015 were $1.1 billion.